These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15614692)

  • 1. Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.
    Palmu AA; Jokinen JT; Kaijalainen T; Leinonen M; Karma P; Kilpi TM
    Clin Infect Dis; 2005 Jan; 40(1):52-7. PubMed ID: 15614692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
    N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.
    McEllistrem MC; Adams JM; Patel K; Mendelsohn AB; Kaplan SL; Bradley JS; Schutze GE; Kim KS; Mason EO; Wald ER
    Clin Infect Dis; 2005 Jun; 40(12):1738-44. PubMed ID: 15909260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of clinical signs and symptoms with bacterial findings in acute otitis media.
    Palmu AA; Herva E; Savolainen H; Karma P; Mäkelä PH; Kilpi TM
    Clin Infect Dis; 2004 Jan; 38(2):234-42. PubMed ID: 14699456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R
    Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2006 Jul; 25(7):602-7. PubMed ID: 16804429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
    Veenhoven R; Bogaert D; Uiterwaal C; Brouwer C; Kiezebrink H; Bruin J; IJzerman E; Hermans P; de Groot R; Zegers B; Kuis W; Rijkers G; Schilder A; Sanders E
    Lancet; 2003 Jun; 361(9376):2189-95. PubMed ID: 12842372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.
    Shea KM; Weycker D; Stevenson AE; Strutton DR; Pelton SI
    Vaccine; 2011 Oct; 29(45):8042-8. PubMed ID: 21871518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
    Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
    Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel.
    Porat N; Barkai G; Jacobs MR; Trefler R; Dagan R
    J Infect Dis; 2004 Feb; 189(3):385-92. PubMed ID: 14745695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
    Jokinen JT; Ahman H; Kilpi TM; Mäkelä PH; Käyhty MH
    J Infect Dis; 2004 Aug; 190(3):545-50. PubMed ID: 15243930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A].
    Mahjoub-Messai F; Doit C; Mariani-Kurkdjian P; François M; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1713-6. PubMed ID: 18926673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
    Palmu AA; Saukkoriipi A; Jokinen J; Leinonen M; Kilpi TM
    Vaccine; 2009 Mar; 27(10):1490-1. PubMed ID: 19168111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.
    Poolman J; Kriz P; Feron C; Di-Paolo E; Henckaerts I; Miseur A; Wauters D; Prymula R; Schuerman L
    Vaccine; 2009 May; 27(24):3213-22. PubMed ID: 19446194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?
    Leibovitz E; Satran R; Piglansky L; Raiz S; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 Jun; 22(6):509-15. PubMed ID: 12799507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.